ESTRO 2024 - Abstract Book

S993

Clinical - Gynaecology

ESTRO 2024

16. Mackillop WJ, Pringle JF. Stage III endometrial carcinoma. A review of 90 cases. Cancer. 1985 Nov 15;56(10):2519–23.

17. Conway JL, Lukovic J, Ferguson SE, Zhang J, Xu W, Dhani N, et al. Clinical Outcomes of Surgically Unresectable Endometrial Cancers. Am J Clin Oncol. 2019 Oct;42(10):777–82.

18. Dankulchai P, Petsuksiri J, Chansilpa Y, Hoskin PJ. Image-guided high-dose-rate brachytherapy in inoperable endometrial cancer. Br J Radiol. 2014 Jul;87(1039):20140018.

19. Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, et al. The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018 Feb;9:48–60. 20. Vargo JA, Boisen MM, Comerci JT, Kim H, Houser CJ, Sukumvanich P, et al. Neoadjuvant radiotherapy with or without chemotherapy followed by extrafascial hysterectomy for locally advanced endometrial cancer clinically extending to the cervix or parametria. Gynecol Oncol. 2014 Nov;135(2):190–5. 21. Iheagwara UK, Vargo JA, Chen KS, Burton DR, Taylor SE, Berger JL, et al. Neoadjuvant Chemoradiation Therapy Followed by Extrafascial Hysterectomy in Locally Advanced Type II Endometrial Cancer Clinically Extending to Cervix. Pract Radiat Oncol. 2019 Jul;9(4):248–56.

22. Gannavarapu BS, Hrycushko B, Jia X, Albuquerque K. Upfront radiotherapy with brachytherapy for medically inoperable and unresectable patients with high-risk endometrial cancer. Brachytherapy. 2020 Mar;19(2):139–45.

23. Horne Z, Vargo JA, Comerci JT, Beriwal S. Complete Pathologic Response Following Neoadjuvant Chemoradiotherapy and High-Dose-Rate Brachytherapy for Locally Advanced Endometrial Carcinoma. Cureus [Internet]. 2015 Dec 15 [cited 2023 Feb 8]; Available from: http://www.cureus.com/articles/3888-complete pathologic-response-following-neoadjuvant-chemoradiotherapy-and-high-dose-rate-brachytherapy-for-locally advanced-endometrial-carcinoma

24. Khouri OR, Frey MK, Musa F, Muggia F, Lee J, Boyd L, et al. Neoadjuvant chemotherapy in patients with advanced endometrial cancer. Cancer Chemother Pharmacol. 2019 Aug;84(2):281–5.

25. De Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, et al. Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial. The Lancet Oncology. 2019 Sep;20(9):1273–85.

26. Matei D, Filiaci V, Randall ME, Mutch D, Steinhoff MM, DiSilvestro PA, et al. Adjuvant Chemotherapy plus Radiation for Locally Advanced Endometrial Cancer. N Engl J Med. 2019 Jun 13;380(24):2317–26.

603

Proffered Paper

SBRT and artificial intelligence in oligometastatic GYN-cancers: a real-world study.

Gabriella Macchia 1 , Savino Cilla 2 , Donato Pezzulla 1 , Maura Campitelli 3 , Concetta Laliscia 4 , Roberta Lazzari 5 , Lorena Draghini 6 , Andrei Fodor 7 , Giuseppe D'Agostino 8 , Donatella Russo 9 , Vittoria Balcet 10 , Martina Ferioli 11 , Lisa Vicenzi 12 , Arcangela Raguso 13 , Vanessa Di Cataldo 14 , Valeria Epifani 15 , Simona Borghesi 16 , Aida Di Stefano 17 , Edy Ippolito 12 ,